Last10K.com

Authentidate Holding Corp (ADAT) SEC Filing 10-Q Quarterly report for the period ending Sunday, December 31, 2017

Authentidate Holding Corp

CIK: 885074 Ticker: ADAT
Document And Entity Information - shares
6 Months Ended
Dec. 31, 2017
Jan. 19, 2018
Document Information [Line Items]  
Entity Registrant NameAUTHENTIDATE HOLDING CORP 
Entity Central Index Key0000885074 
Trading Symboladat 
Current Fiscal Year End Date--06-30 
Entity Filer CategorySmaller Reporting Company 
Entity Current Reporting StatusYes 
Entity Voluntary FilersNo 
Entity Well-known Seasoned IssuerNo 
Entity Common Stock, Shares Outstanding (in shares) 7,249,370
Document Type10-Q 
Document Period End DateDec. 31, 2017 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusQ2 
Amendment Flagfalse 

View differences made from one quarter to another to evaluate Authentidate Holding Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Authentidate Holding Corp.

Continue

Assess how Authentidate Holding Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Authentidate Holding Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Note 3 - Restatement And Correction Of Error
Condensed Consolidated Balance Sheets (current Period Unaudited)
Condensed Consolidated Balance Sheets (current Period Unaudited) (parentheticals)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Income (unaudited)
Note 1 - Description Of Business, Reverse Merger And Liquidity
Note 1 - Description Of Business, Reverse Merger And Liquidity (details Textual)
Note 10 - Commitments And Contingencies
Note 10 - Commitments And Contingencies (details Textual)
Note 11 - Related Party Transactions
Note 11 - Related Party Transactions (details Textual)
Note 12 - Segment Information
Note 12 - Segment Information (details Textual)
Note 12 - Segment Information (tables)
Note 12 - Segment Information - Selected Financial Information (details)
Note 13 - Subsequent Events
Note 13 - Subsequent Events (details Textual)
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies (details Textual)
Note 3 - Restatement And Correction Of Error (tables)
Note 3 - Restatement And Correction Of Error - Restated Statements Of Income And Cash Flows (details)
Note 4 - Inventory
Note 4 - Inventory (details Textual)
Note 4 - Inventory (tables)
Note 4 - Inventory - Inventory (details)
Note 5 - Income Taxes
Note 5 - Income Taxes (details Textual)
Note 6 - Related Party Notes Payable
Note 6 - Related Party Notes Payable (details Textual)
Note 6 - Related Party Notes Payable (tables)
Note 6 - Related Party Notes Payable - Related Party Notes Payable (details)
Note 7 - Equity
Note 7 - Equity (details Textual)
Note 7 - Equity (tables)
Note 7 - Equity - Earnings Per Share (details)
Note 7 - Equity - Warrant Activity (details)
Note 8 - Share-based Compensation
Note 8 - Share-based Compensation (details Textual)
Note 8 - Share-based Compensation (tables)
Note 8 - Share-based Compensation - Restricted Stock Unit Activity (details)
Note 8 - Share-based Compensation - Stock Option Activity (details)
Note 9 - Fair Value Measurements And Other Financial Instruments
Note 9 - Fair Value Measurements And Other Financial Instruments (details Textual)
Note 9 - Fair Value Measurements And Other Financial Instruments (tables)
Note 9 - Fair Value Measurements And Other Financial Instruments - Derivative Liabilities (details)
Note 9 - Fair Value Measurements And Other Financial Instruments - Summary In Changes In Fair Value (details)
Note 9 - Fair Value Measurements And Other Financial Instruments - Valuation Techniques (details)
Significant Accounting Policies (policies)
Ticker: ADAT
CIK: 885074
Form Type: 10-Q Quarterly Report
Accession Number: 0001437749-18-001212
Submitted to the SEC: Fri Jan 26 2018 4:03:44 PM EST
Accepted by the SEC: Fri Jan 26 2018
Period: Sunday, December 31, 2017
Industry: Medical Laboratories

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/adat/0001437749-18-001212.htm